Avalon globocare corp ALBT.US 總覽分析

美股醫療保健
(ALBT 無簡報檔)

ALBT 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分較低,若以價值投資為目標,已經有長期投資部位可能需陸續減碼

ALBT 近期報酬表現

-0.64%

Avalon globocare corp

4.57%

同產業平均

3.26%

S&P500

與 ALBT 同產業的標的表現

  • MRNO Murano global investments plc
    價值 -趨勢 3 分波段 4 分籌碼 -股利 1 分
    查看更多

ALBT 公司資訊

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

ALBT 股價